Almiramides A−C: Discovery and Development of a New Class of Leishmaniasis Lead Compounds
- 27 May 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (10), 4187-4197
- https://doi.org/10.1021/jm100265s
Abstract
Leishmaniasis is a debilitating disease caused by protozoan parasites of the genus Leishmania, which affects an estimated 12 million people worldwide. The discovery of new lead compounds for leishmaniasis is therefore a pressing concern for global health programs. The organic extract of a Panamanian collection of the marine cyanobacterium Lyngbya majuscula showed strong in vitro activity in two complementary screens against the tropical parasite Leishmania donovani, the causative agent of visceral leishmaniasis. Chromatographic separation of this complex mixture led to the isolation of the highly N-methylated linear lipopeptides, almiramides A−C (1−3). Comparison with the biological activities of a number of related metabolites and semisynthetic derivatives revealed key features required for activity and afforded one new compound (11) with superior in vitro activity. Subsequent synthesis of a library of simplified analogues led to the discovery of several compounds with improved therapeutic indices to the natural products.Keywords
This publication has 13 references indexed in Scilit:
- Antileishmanial Constituents of the Panamanian Endophytic Fungus Edenia sp.Journal of Natural Products, 2008
- Complexities of Assessing the Disease Burden Attributable to LeishmaniasisPLoS Neglected Tropical Diseases, 2008
- Leishmaniases' Burden of Disease: Ways Forward for Getting from Speculation to RealityPLoS Neglected Tropical Diseases, 2008
- N-Methylation of Peptides: A New Perspective in Medicinal ChemistryAccounts of Chemical Research, 2008
- Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin AnaloguesAngewandte Chemie-International Edition, 2008
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?Nature Reviews Microbiology, 2007
- Antimalarial Linear Lipopeptides from a Panamanian Strain of the Marine Cyanobacterium Lyngbya majusculaJournal of Natural Products, 2007
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- A NOVEL DNA-BASED MICROFLUORIMETRIC METHOD TO EVALUATE ANTIMALARIAL DRUG ACTIVITYThe American Journal of Tropical Medicine and Hygiene, 2004
- Aporphine Alkaloids fromGuatteriaspp. with Leishmanicidal ActivityPlanta Medica, 2003